Loading...

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2019–2026

A01787
Pages: 239
Jan 2020 | 12874 Views
 
Author(s) : Surabhi Pandey and Onkar Sumant
Tables: 118
Charts: 42
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Therapeutics Market

Request Now !

The global digital therapeutics market size was valued at $2.24 billion in 2018 and is expected to reach $9.64 billion by 2026 with a CAGR of 19.9% during the forecast period.

Digital therapeutics is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes for patients. For instance, digital therapeutics does not include consumer health-oriented technologies such as step-counters and calorie-counters. It’s a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. In addition, it utilizes digital health technologies to treat a psychological condition. Hence, these aforementioned factors help in increasing the global digital therapeutics market share across the world. 

Digital Therapeutics Market

Get more information on this report : Request Sample Pages

 

The demand for global digital therapeutics is increasing due to increase in adoption of smartphones and tablets, coupled with healthcare apps; growth in need to control healthcare costs; and rise in incidence of chronic diseases. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the digital therapeutics market growth. On the contrary, high growth opportunities in untapped markets are expected to provide significant profitable opportunities for manufacturers in the digital therapeutics industry.

Application Segment Review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period. This is attributed to increasing number of overweight populations thereby, increasing number of chronic diseases due to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing the prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Digital Therapeutics Market
By Application

Your browser does not support the canvas element.

Diabetes holds the dominant position in 2018 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Product Segment Review

Depending on the product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use the existing software and develop new and advanced features, to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Digital Therapeutics Market
By Product

Your browser does not support the canvas element.

Software segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Region Segment Review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Digital Therapeutics Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 21.7% during 2019-2026.

Get more information on this report : Request Sample Pages

The report provides a comprehensive analysis of the key players operating in the global digital therapeutics market, namely 2MORROW, Inc., Fitbit, Inc. (Twine Health, Inc.), Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc. The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.

Key Benefits for Stakeholders:

  • This report provides a detailed quantitative analysis of the current digital therapeutics market trends and forecast estimations from 2018 to 2026, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2026, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global digital therapeutics market.

Key Market Segments:

By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product Type

  • Software
  • Device

By Sales Channel

  • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Turkey
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top player positioning, 2018

3.3. Porter’s five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in adoption of smartphones and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases

3.4.2. Restraints

3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns

3.4.3. Opportunity

3.4.3.1. Emerging markets offer significant growth opportunities

CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Diabetes

4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Obesity

4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Cardiovascular diseases

4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Central nervous system (CNS) diseases

4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Gastrointestinal disorder

4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Respiratory diseases

4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

4.8. Smoking cessation

4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country

4.9. Others

4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country

CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1. Overview

5.1.1. Market size and forecast

5.2. Software

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Devices

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1. Overview

6.1.1. Market size and forecast

6.2. Business-to-business (B2B)

6.2.1. Market size and forecast, by type
6.2.2. Employer

6.2.2.1. Market size and forecast

6.2.3. Healthcare Providers

6.2.3.1. Market size and forecast

6.2.4. Others

6.2.4.1. Market size and forecast

6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country

6.3. Business-to-consumers

6.3.1. Market size and forecast, by type
6.3.2. Patients

6.3.2.1. Market size and forecast

6.3.3. Caregivers

6.3.3.1. Market size and forecast

6.3.4. Market size and forecast, by region
6.3.5. Market analysis, by country

CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country

7.2.2.1. U.S. digital therapeutics market, by application
7.2.2.2. U.S digital therapeutics market, by product type
7.2.2.3. U.S. digital therapeutics market, by sales channel
7.2.2.4. Canada digital therapeutics market, by application
7.2.2.5. Canada digital therapeutics market, by product type
7.2.2.6. Canada digital therapeutics market, by sales channel
7.2.2.7. Mexico digital therapeutics market, by application
7.2.2.8. Mexico digital therapeutics market, by product type
7.2.2.9. Mexico digital therapeutics market, by sales channel

7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country

7.3.2.1. UK digital therapeutics market, by application
7.3.2.2. UK digital therapeutics market, by product type
7.3.2.3. UK digital therapeutics market, by sales channel
7.3.2.4. Germany digital therapeutics market, by application
7.3.2.5. Germany digital therapeutics market, by product type
7.3.2.6. Germany digital therapeutics market, by sales channel
7.3.2.7. France digital therapeutics market, by application
7.3.2.8. France digital therapeutics market, by product type
7.3.2.9. France digital therapeutics market, by sales channel
7.3.2.10. Italy digital therapeutics market, by application
7.3.2.11. Italy digital therapeutics market, by product type
7.3.2.12. Italy digital therapeutics market, by sales channel
7.3.2.13. Spain digital therapeutics market, by application
7.3.2.14. Spain digital therapeutics market, by product type
7.3.2.15. Spain digital therapeutics market, by sales channel
7.3.2.16. Rest of Europe digital therapeutics market, by application
7.3.2.17. Rest of Europe digital therapeutics market, by product type
7.3.2.18. Rest of Europe digital therapeutics market, by sales channel

7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel

7.4. Asia-pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country

7.4.2.1. Japan digital therapeutics market, by application
7.4.2.2. Japan digital therapeutics market, by product type
7.4.2.3. Japan digital therapeutics market, by sales channel
7.4.2.4. China digital therapeutics market, by application
7.4.2.5. China digital therapeutics market, by product type
7.4.2.6. China digital therapeutics market, by sales channel
7.4.2.7. Australia digital therapeutics market, by application
7.4.2.8. Australia digital therapeutics market, by product type
7.4.2.9. Australia digital therapeutics market, by sales channel
7.4.2.10. India digital therapeutics market, by application
7.4.2.11. India digital therapeutics market, by product type
7.4.2.12. India digital therapeutics market, by sales channel
7.4.2.13. South Korea digital therapeutics market, by application
7.4.2.14. South Korea digital therapeutics market, by product type
7.4.2.15. South Korea digital therapeutics market, by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market, by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market, by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market, by sales channel

7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country

7.5.2.1. Brazil digital therapeutics market, by application
7.5.2.2. Brazil digital therapeutics market, by product type
7.5.2.3. Brazil digital therapeutics market, by sales channel
7.5.2.4. Turkey digital therapeutics market, by application
7.5.2.5. Turkey digital therapeutics market, by product type
7.5.2.6. Turkey digital therapeutics market, by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market, by application
7.5.2.8. Saudi Arabia digital therapeutics market, by product type
7.5.2.9. Saudi Arabia digital therapeutics market, by sales channel
7.5.2.10. South Africa digital therapeutics market, by application
7.5.2.11. South Africa digital therapeutics market, by product type
7.5.2.12. South Africa digital therapeutics market, by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market, by application
7.5.2.14. Rest of LAMEA digital therapeutics market, by product type
7.5.2.15. Rest of LAMEA digital therapeutics market, by sales channel

7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel

CHAPTER 8: COMPANY PROFILES

8.1. 2MORROW, INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments

8.2. FITBIT, INC. (TWINE HEALTH, INC.)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. LIVONGO HEALTH, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments

8.4. MEDTRONIC PLC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. OMADA HEALTH, INC.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Key strategic moves and developments

8.6. PEAR THERAPEUTICS, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments

8.7. PROTEUS DIGITAL HEALTH, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments

8.8. RESMED, INC. (PROPELLER HEALTH)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. VOLUNTIS, INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. WELLDOC, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2018–2026 ($MILLION)
TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2018–2026 ($MILLION)
TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2018–2026 ($MILLION)
TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2026 ($MILLION)
TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2018–2026 ($MILLION)
TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2018–2026 ($MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2018–2026 ($MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2018–2026 ($MILLION)
TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2018–2026 ($MILLION)
TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2018–2026 ($MILLION)
TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2018–2026 ($MILLION)
TABLE 20. DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2026 ($MILLION)
TABLE 97. 2MORROW: COMPANY SNAPSHOT
TABLE 98. WELLDOC: PRODUCT PORTFOLIO
TABLE 99. FITBIT: COMPANY SNAPSHOT
TABLE 100. FITBIT: PRODUCT PORTFOLIO
TABLE 101. LIVONGO: COMPANY SNAPSHOT
TABLE 102. LIVONGO: PRODUCT PORTFOLIO
TABLE 103. MEDTRONIC: COMPANY SNAPSHOT
TABLE 104. MEDTRONIC: OPERATING SEGMENTS
TABLE 105. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 106. OMADA: COMPANY SNAPSHOT
TABLE 107. PEAR: COMPANY SNAPSHOT
TABLE 108. PEAR: PRODUCT PORTFOLIO
TABLE 109. PROTEUS: COMPANY SNAPSHOT
TABLE 110. PROTEUS: PRODUCT PORTFOLIO
TABLE 111. RESMED: COMPANY SNAPSHOT
TABLE 112. RESMED: OPERATING SEGMENTS
TABLE 113. RESMED: PRODUCT PORTFOLIO
TABLE 114. VOLUNTIS: COMPANY SNAPSHOT
TABLE 115. VOLUNTIS: OPERATING SEGMENTS
TABLE 116. VOLUNTIS: PRODUCT PORTFOLIO
TABLE 117. WELLDOC: COMPANY SNAPSHOT
TABLE 118. WELLDOC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN IGITAL THERAPEUTICSS MARKET, 2018
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015–2019*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015–2019* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015–2019*
FIGURE 06. TOP PLAYER POSITIONING, 2018
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH BARGAINING POWER OF BUYERS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. MODERATE THREAT OF NEW ENTRANT
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION
FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY COUNTRY,  2018 & 2026, ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY,  2018 & 2026 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY,  2018 & 2026 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY,  2018 & 2026 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY,  2018 & 2026 ($MILLION)
FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY,  2017 & 2024 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY,  2018 & 2026 (%)
FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
FIGURE 26. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER,  2018–2026 ($MILLION)
FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 2018–2026 ($MILLION)
FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS,  2018–2026 ($MILLION)
FIGURE 29. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2018 & 2026 ($MILLION)
FIGURE 30. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS,  2018–2026 ($MILLION)
FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS,  2018–2026 ($MILLION)
FIGURE 32. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2018 & 2026 ($MILLION)
FIGURE 33. FITBIT: NET SALES, 2016–2018 ($MILLION)
FIGURE 34. FITBIT: NET SALES BY REGION, 2018 (%)
FIGURE 35. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 36. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 37. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 38. RESMED: NET SALES, 2016–2018 ($MILLION)
FIGURE 39. RESMED: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 40. VOLUNTIS: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. VOLUNTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42. VOLUNTIS: REVENUE SHARE BY REGION, 2018 (%)

 
 

The global digital therapeutics market is in its nascent stage, and has gained significant attention over the past few years. The market has piqued the interest of healthcare providers, patients, and practioners, owing to several benefits offered by these devices to reduce healthcare expenditure, improve patient & doctor communication, and manage patient health efficiently. Moreover, there have been remarkable advances in the development of novel digital therapeutics applications to provide advanced management options of chronic disease patients and maintain a healthy lifestyle. As the market is saturated and is growing at a steady rate in the developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players in this market.

In addition, rapid penetration of smart devices and smartphones is projected to increase the usage of digital therapeutics globally. At present, the developing economies have witnessed an increase in adoption of these devices for wellness management, such as fitness, diet & nutrition, and lifestyle & stress, which further boosts the growth of the market.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market value of global digital therapeutics market was $2,238 million in 2018.

A. Emerging countries of Asia-Pacific region are growing at a growth% of 21.7%. India, China, South Korea, Australia are expected grow at a CAGR of 25.7%, 23.1%, 22.6%, 20.9% respectively.

A. The market value of global digital therapeutics market in 2019 is $2,700 million.

A. the adoption of advanced smartphone applications and smart devices of digital therapeutics is expected to increase due to rise in incidence of chronic diseases such as diabetes and obesity.

A. The base year is 2018 in digital therapeutics market

A. Increase in adoption of smartphones and tablets coupled with healthcare applications

A. The North America market held a major share in the digital therapeutics market in 2018 and is expected to continue the trend in the forecasting period. This is attributed to high prevelance of diabetic patients in this region.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Digital Therapeutics Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts